Condition
ALK Gene Mutation clinical trials and research
As of November 12, 2026, Find a Trial lists 6 ALK Gene Mutation clinical trials that are recruiting, at sites in 5 countries (most in China (2), Sweden (1), Mexico (1)). By phase: Phase 2 (3), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 6Clinical trials
- 5Countries
Newest ALK Gene Mutation clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Combining chemotherapy with Lorlatinib for ALK positive lung cancer | Phase 2 | Aviano and 8 other locations | Recruiting | Apr 23, 2024 |
| Combining Alectinib with Radiation Therapy for Advanced Lung Cancer with ALK Mutation | — | Stockholm | Recruiting | Feb 13, 2023 |
| Evaluating alectinib in patients with advanced lung cancer | Phase 1/2 | Mexico City, Mexico City | Recruiting | Feb 6, 2023 |
| Combining Pembrolizumab, Bevacizumab, and Chemotherapy for Advanced Lung Cancer with ALK Mutation | Phase 2 | Changsha, Hunan | Recruiting | Mar 4, 2022 |
| Treatment options for advanced lung cancer with specific genetic mutations | Phase 2 | Changsha, Hunan | Recruiting | Mar 26, 2020 |
| Identifying tumor survival mechanisms in lung cancer after targeted therapy | — | Aurora, Colorado | Recruiting | Feb 3, 2017 |
All recruiting trials (6)
-
Combining chemotherapy with Lorlatinib for ALK positive lung cancer
This study is testing if combining chemotherapy with Lorlatinib can help people with ALK positive lung cancer who have seen their disease get worse while on Lorlatinib.
-
Combining Alectinib with Radiation Therapy for Advanced Lung Cancer with ALK Mutation
This study is testing if combining alectinib with targeted radiation therapy can help people with advanced lung cancer that has an ALK mutation feel better and live longer.
-
Evaluating alectinib in patients with advanced lung cancer
This study is testing how well alectinib works and how the body processes it in Mexican patients with advanced lung cancer that has a specific genetic change.
-
Combining Pembrolizumab, Bevacizumab, and Chemotherapy for Advanced Lung Cancer with ALK Mutation
This study is testing a new combination of two drugs and chemotherapy to see if it helps people with advanced lung cancer that has an ALK mutation and hasn't improved with another treatment.
-
Treatment options for advanced lung cancer with specific genetic mutations
This study is testing different targeted treatments for people with advanced lung cancer that have specific genetic mutations to see which ones can help them live longer and feel better.
-
Identifying tumor survival mechanisms in lung cancer after targeted therapy
This study is trying to see how lung cancer tumors change before and after treatment with a specific drug to find ways to make the treatment work better.
Related topics
Quick answers
How many ALK Gene Mutation clinical trials are recruiting right now?
6, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 5 countries. The most sites are in China (2 trials), Sweden (1 trial), Mexico (1 trial), Italy (1 trial), United States (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 3, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.